» Articles » PMID: 9792667

Inactivation of Tumor Suppressor P53 by Mot-2, a Hsp70 Family Member

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Oct 29
PMID 9792667
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

The mortalin genes, mot-1 and mot-2, are hsp70 family members that were originally cloned from normal and immortal murine cells, respectively. Their proteins differ by only two amino acid residues but exhibit different subcellular localizations, arise from two distinct genes, and have contrasting biological activities. We report here that the two proteins also differ in their interactions with the tumor suppressor protein p53. The pancytosolic mot-1 protein in normal cells did not show colocalization with p53; in contrast, nonpancytosolic mot-2 and p53 overlapped significantly in immortal cells. Transfection of mot-2 but not mot-1 resulted in the repression of p53-mediated transactivation in p53-responsive reporter assays. Inactivation of p53 by mot-2 was supported by the down-regulation of p53-responsive genes p21(WAF-1) and mdm-2 in mot-2-transfected cells only. Furthermore, NIH 3T3 cells transfected with expression plasmid encoding green fluorescent protein-tagged mot-2 but not mot-1 showed an abrogation of nuclear translocation of wild-type p53. These results demonstrate a novel mechanism of p53 inactivation by mot-2 protein.

Citing Articles

eIF4A1 exacerbates myocardial ischemia-reperfusion injury in mice by promoting nuclear translocation of transgelin/p53.

Li D, Hu X, Tian Z, Ning Q, Liu J, Yue Y Acta Pharmacol Sin. 2025; .

PMID: 39856433 DOI: 10.1038/s41401-024-01467-6.


Decoding the molecular symphony: interactions between the mA and p53 signaling pathways in cancer.

Shoemaker R, Huang M, Wu Y, Huang C, Lee D NAR Cancer. 2024; 6(3):zcae037.

PMID: 39329012 PMC: 11426327. DOI: 10.1093/narcan/zcae037.


Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.

Pan M, Solozobova V, Kuznik N, Jung N, Grassle S, Gourain V Cancer Res Commun. 2023; 3(7):1378-1396.

PMID: 37520743 PMC: 10373600. DOI: 10.1158/2767-9764.CRC-23-0111.


Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1.

Meidinna H, Shefrin S, Sari A, Zhang H, Dhanjal J, Kaul S Front Cell Dev Biol. 2022; 10:918970.

PMID: 36172283 PMC: 9510692. DOI: 10.3389/fcell.2022.918970.


Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type and p53 mutant.

Shefrin S, Sari A, Kumar V, Zhang H, Meidinna H, Kaul S Curr Res Struct Biol. 2022; 4:320-331.

PMID: 36164647 PMC: 9507986. DOI: 10.1016/j.crstbi.2022.09.002.